The is accepting Letters of Intent from investigators for basic science, clinical, population/epidemiologic, and translational research on cardiomyopathies affecting children age 18 and younger.
Grants of up to $50,000 will be awarded to studies focused on the causes, diagnosis, or treatment of dilated, hypertrophic, restrictive, arrhythmogenic right ventricular, and left ventricular non-compaction cardiomyopathy. The grants are designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the National Institutes of Health and other major granting institutions.
To be eligible, principal investigators must hold an MD, PhD, or equivalent degree and reside in the United States or Canada. In addition, the PI must have a faculty appointment at an accredited U.S. or Canadian medical institution and have the ability to conduct independent research with publications in established peer-reviewed medical and scientific journals.
Letters of Intent must be received no later than June 13. Upon review, selected applicants will be invited to submit complete applications by September 7, 2018.
See the Children's Cardiomyopathy Foundation website for complete program guidelines and application instructions.